Gabriele Elena, Ricci Chiara, Meneghetti Fiorella, Ferri Nicola, Asai Akira, Sparatore Anna
a Department of Pharmaceutical Sciences , Università degli Studi di Milano , Milano , Italy.
b Department of Pharmacological and Biomolecular Sciences , Università degli Studi di Milano , Milano , Italy.
J Enzyme Inhib Med Chem. 2017 Dec;32(1):337-344. doi: 10.1080/14756366.2016.1252757.
With the aim to discover new STAT3 direct inhibitors, potentially useful as anticancer agents, a set of methanethiosulfonate drug hybrids were synthesized. The in vitro tests showed that all the thiosulfonic compounds were able to strongly and selectively bind STAT3-SH2 domain, whereas the parent drugs were completely devoid of this ability. In addition, some of them showed a moderate antiproliferative activity on HCT-116 cancer cell line. These results suggest that methanethiosulfonate moiety can be considered a useful scaffold in the preparation of new direct STAT3 inhibitors. Interestingly, an unusual kind of organo-sulfur derivative, endowed with valuable antiproliferative activity, was occasionally isolated. [Formula: see text].
为了发现可能用作抗癌剂的新型STAT3直接抑制剂,合成了一组甲硫基磺酸盐药物杂化物。体外试验表明,所有硫代磺酸化合物都能强烈且选择性地结合STAT3-SH2结构域,而母体药物则完全没有这种能力。此外,其中一些化合物对HCT-116癌细胞系表现出适度的抗增殖活性。这些结果表明,甲硫基磺酸盐部分可被视为制备新型直接STAT3抑制剂的有用支架。有趣的是,偶尔会分离出一种具有有价值抗增殖活性的不寻常有机硫衍生物。[分子式:见原文]